Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In previous articles I have highlighted a few companies I think are strong M&A targets for future proofing pipelines of larger pharma companies looking to move into or maintain a position in the obesity and T2D field
DPP-4 inhibitors (DPP-4i) are commonly used as hypoglycemic agents
(D) Organ weight and (E) fat and lean mass measured at the end of the experiment
Glucose Intolerance Caused by a Defect in the Entero-Insular Axis: A Study in Gastric Inhibitory Polypeptide Receptor Knockout Mice
US$ 25.42
US$ 28.15
US$ 28.14
US$ 28.63
US$ 25.06
US$ 24.61
US$ 22.18
US$ 28.38
US$ 25.43
US$ 21.27
US$ 23.69
US$ 21.82
US$ 20.25
